HSBC Plans Biffa Seizure and 4 Stocks Enjoying 52-Week Highs
HSBC Holdings (NYSE:HBC intends to takeover Biffa, which is a waste management business, once its owners gave up their struggle against crippling debts, according to Dow Jones citing The Sunday Times. Shares closed up 1.7 percent on the day at $47.25 and have traded in a 52-week range of $35.72 to $47.80.
International Business Machines Corporation (NYSE:IBM) is collaborating with ESB to implement a fully integrated smarter charging information tech system that will help manage electric vehicle public charge-points which are being launched across Ireland by ESB Networks. Working together, the firms will permit EV drivers to access, charge and pay using an identification card. This project will supply utilities with access to energy usage data that should improve smart grid operations, decrease power strain during peak charging periods, and ensure reliable energy distribution to customers. Shares closed up 1.46 percent on the day at $210.47 and have been traded in a 52-week range of $168.88 to $210.69.
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>
Memorial Production Partners (NASDAQ:MEMP) has closed its previously announced purchase of oil and natural gas properties in East Texas from Goodrich Petroleum Corporation for $93.2 million. The transaction was funded with borrowings under the firm’s current credit facility and the effective date is July 1st. The acquisition should be immediately accretive to distributable cash flow per unit along with net asset value per unit as it improves Memorial Production’s operating margin. Shares closed up 1.27 percent on the day at $19.13 and have traded in a 52-week range of $15.71 to $19.14.
Morningstar (NASDAQ:MORN) purchased a 34 percent equity investment in Inquiry Financial Europe AB which is based in Bromma, Sweden. The firm offers granular, company-specific consensus estimates that are drawn directly from analysts’ research, such as divisional breakdowns of forecast sales and units shipped, to exactly reflect the analysts’ models. Shares closed up 1.69 percent on the day at $63.70 having been traded in a 52-week range of $54.01 to $63.57.
Novartis (NYSE:NVS) reports that the European Commission has okayed the Seebri Breezhaler 44 mcg delivered dose as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients suffering from chronic obstructive pulmonary disease, or COPD. On September 28th once-daily Seebri Inhalation Capsules 50 mcg were approved in Japan. Shares closed up 0.83 percent on the day at $61.77 and have traded in a 52-week range of $51.20 to $61.89.
Don’t Miss: What’s Next for Pfizer?